PATENT CLAIM ANALYSIS

Application Number: 15939066
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "093400"]

Abstract:
Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.

Claim (Index 7):
The pharmaceutical composition of  claim 1 , wherein the at least one species of  Roseomonas  genus bacterium comprises  Roseomonas aerilata, Roseomonas aerophila, Roseomonas aestuarii, Roseomonas alkaliterrae, Roseomonas aquatic, Roseomonas cervicalis, Roseomonas fauriae, Roseomonas frigidaquae, Roseomonas gilardii, Roseomonas lacus, Roseomonas ludipueritiae, Roseomonas mucosa, Roseomonas pecuniae, Roseomonas rhizosphaerae, Roseomonas riguiloci, Roseomonas rosea, Roseomonas soli, Roseomonas stagni, Roseomonas terrae , or  Roseomonas vinacea.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 1.32353
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15662691', '13394113', '14286308', '15556953', '15775085']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6732809547171239
- 35 USC 102 Novelty (BERT): 0.5067310244104006
- Combined Prediction Score: 0.6566259616864516
- Mean Citation Score: 163.15910200000005
- Max Citation Score: 188.28313
- Similarity Product: 116.03865486753048

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test